Concert Pharmaceuticals, Inc.
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel small molecule drugs. This approach starts with approved drugs in which deuterium substitution has the potential to enhance clinical safety, tolerability or efficacy. The Company is developing a broad pipeline of innovative medicines targeting autoimmune and inflammatory diseases and central nervous systems (CNS) disorders.